Viewing Study NCT04116359


Ignite Creation Date: 2025-12-24 @ 2:33 PM
Ignite Modification Date: 2026-02-02 @ 10:10 PM
Study NCT ID: NCT04116359
Status: WITHDRAWN
Last Update Posted: 2020-09-28
First Post: 2019-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-09-18
Start Date Type: ACTUAL
Primary Completion Date: 2020-09-18
Primary Completion Date Type: ACTUAL
Completion Date: 2020-09-18
Completion Date Type: ACTUAL
First Submit Date: 2019-10-03
First Submit QC Date: None
Study First Post Date: 2019-10-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-09-25
Last Update Post Date: 2020-09-28
Last Update Post Date Type: ACTUAL